Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02817204
What this trial is testing

Effect of Aerobic EXercise on MiCroVAscular RarefacTION in Chinese Mild HyperteNsive Patients（EXCAVATION-CHN1）

Who this might be right for
Primary Hypertension
First Affiliated Hospital, Sun Yat-Sen University 40
Large-scale testing (Phase 3)Study completedNCT00171405
What this trial is testing

A Clinical Study to Evaluate the Long-term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg

Who this might be right for
Hypertension
Novartis 250
Not applicableUnknownNCT05912322
What this trial is testing

Evaluation of Black Chokeberry Bio Juice on Blood Pressure Levels and Endothelial Damage

Who this might be right for
Essential HypertensionEndothelial DysfunctionInflammation
University of Medicine and Pharmacy "Victor Babes" Timisoara 100
Testing effectiveness (Phase 2)Study completedNCT02194465
What this trial is testing

LY2623091 in Participants With High Blood Pressure

Who this might be right for
Primary Hypertension
Eli Lilly and Company 304
Early research (Phase 1)Study completedNCT06226727
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-1" and "BR1019-2"

Who this might be right for
Type 2 Diabetes MellitusEssential Hypertension
Boryung Pharmaceutical Co., Ltd 52
Not applicableNot Yet RecruitingNCT07577323
What this trial is testing

Safety and Efficacy Evaluation of Non-invasive Temporal Interference Stimulation for Blood Pressure Modulation in Patients With Mild Essential Hypertension

Who this might be right for
Essential Hypertension
Xuanwu Hospital, Beijing 60
Large-scale testing (Phase 3)Study completedNCT02166814
What this trial is testing

A Randomized, Double-blind, Multicenter, Phase III Study to Evaluate the Efficacy and Safety of Combination of Fimasartan/Rosuvastatin in Comparison to Each Component Administered Alone in Patients With Essential Hypertension and Dyslipidemia

Who this might be right for
Essential Hypertension, Dyslipidemia
Boryung Pharmaceutical Co., Ltd 140
Large-scale testing (Phase 3)Study completedNCT01541943
What this trial is testing

Efficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia

Who this might be right for
Essential HypertensionHyperlipidemia
HanAll BioPharma Co., Ltd. 356
Not applicableEnrolling By InvitationNCT07307924
What this trial is testing

The Effect of Motivational Interviewing on Knowledge, Self-Efficacy, and Treatment Adherence in Patients With Primary Hypertension Living in Semi-Rural Areas

Who this might be right for
Healthy Individuals (Controls)PRIMARY HYPERTENSION PATIENT
Eskisehir Osmangazi University 100
Testing effectiveness (Phase 2)UnknownNCT01320397
What this trial is testing

Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations

Who this might be right for
Essential Hypertension
RostaQuo S.p.A. 240
Large-scale testing (Phase 3)Study completedNCT01876368
What this trial is testing

Efficacy and Safety of LCZ696 Compared to Olmesartan in Essential Hypertensive Patients Not Responsive to Olmesartan

Who this might be right for
Hypertension
Novartis Pharmaceuticals 376
Not applicableStudy completedNCT00936208
What this trial is testing

PRO-POWER: Hypertension With Risk Factors for a Duration of 24 Weeks With Micardis 80mg/Micardis Plus 80mg/12.5mg

Who this might be right for
Hypertension
Boehringer Ingelheim 3,184
Not applicableStudy completedNCT03847350
What this trial is testing

Observational Study of Efficacy and Safety of Nebivolol in Korean Patients With Essential Hypertension

Who this might be right for
Essential Hypertension
A.Menarini Asia-Pacific Holdings Pte Ltd 3,250
Not applicableLooking for participantsNCT07665034
What this trial is testing

Isometric Resistance Exercise on Accelerated Atherosclerosis in Hypertension

Who this might be right for
Atherosclerosis Cardiovascular Disease
Chinese University of Hong Kong 200
Early research (Phase 1)Study completedNCT06636877
What this trial is testing

Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration of "BR1019-3" and "BR1019-2" in Healthy Volunteers

Who this might be right for
Essential HypertensionType 2 Diabetes
Boryung Pharmaceutical Co., Ltd 52
Large-scale testing (Phase 3)Study completedNCT01838850
What this trial is testing

Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Combination Therapy in Patients With Hypertension Not Controlled With Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy

Who this might be right for
Essential Hypertension
Daiichi Sankyo Korea Co., Ltd., a Daiichi Sankyo Company 344
Post-approval studies (Phase 4)Ended earlyNCT00449618
What this trial is testing

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension

Who this might be right for
High-Normal Blood PressureMild Essential Hypertension
University of Vigo 23
Post-approval studies (Phase 4)Study completedNCT00631917
What this trial is testing

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Who this might be right for
Hypertension
Novartis 774
Testing effectiveness (Phase 2)Study completedNCT00937651
What this trial is testing

Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K)

Who this might be right for
Essential Hypertension
Boryung Pharmaceutical Co., Ltd 81
Post-approval studies (Phase 4)Study completedNCT00646841
What this trial is testing

Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients

Who this might be right for
Hypertension
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 89
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation